10,335,462 (462 Patent)Claim 1 (Paraphrased): A subcutaneous composition: 0.1-10 mg/mL semaglutide, phosphate/citrate/histidine buffer (pH 6.5-8.5), isotonic agent (e.g., propylene glycol), dosed weekly at 0.5/1.0 mg for T2DM.Value: Ensures stability, solubility
They can be used on their own or alongside GLP-1 medications to help enhance metabolism, reduce fatigue, and improve overall wellness
This gel-like mucosal barrier serves as a primary defense mechanism by competitively inhibiting the adhesion of pathogenic bacteria to host surfaces (182, 183)
You may also begin to notice changes in your appetite and weight
Explore RTHM's clinical services and treatment options to learn more about how we can support your journey toward healing, symptom management, and a better quality of life
For some, it appears within minutes of injecting